Translational Development Acquisition Corp. (NASDAQ:TDACU) Sees Significant Growth in Short Interest

Translational Development Acquisition Corp. (NASDAQ:TDACU) saw a significant increase in short interest in the month of August. As of August 31st, there was short interest totaling 6 shares, an increase of 100.0% from the August 15th total of 3 shares. Based on an average trading volume of 20 shares, the days-to-cover ratio is currently 0.3 days.

Translational Development Acquisition Price Performance

Shares of NASDAQ TDACU traded down $0.07 during trading on Tuesday, hitting $12.50. Translational Development Acquisition has a 12-month low of $10.71 and a 12-month high of $17.29. The company’s 50 day simple moving average is $12.11 and its 200-day simple moving average is $11.47.

About Translational Development Acquisition

Translational Development Acquisition Corp. is a blank check acquisition company incorporated in Delaware. The company was formed to effect a merger, stock purchase, asset acquisition, stock exchange, reorganization or similar business combination with one or more businesses, though it has not yet identified a target for its initial transaction.

In early 2021, the company completed its initial public offering and listed its units on the Nasdaq under the ticker TDACU. Each unit comprises one Class A ordinary share and one-third of a warrant to purchase additional Class A shares, with its securities also trading separately as shares and warrants.

Following its IPO, the net proceeds from the offering are held in a trust account until the closing of an initial business combination.